Latest stories on ICCM
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
PR Newswire63 · neutralproduct/pr
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
PR Newswire67 · bullishproduct/pr
Brazil Sees Surge in ProSense Cryoablation Adoption After FDA Nod—Key Studies Aim to Drive Further Growth
MarketChameleon67 · bullishproduct/pr
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
PR Newswire63 · neutralproduct/pr
IceCure Medical Faces Certified Class Action Over 2021 Private Placement, Plans Court Challenge
TipRanks32 · bearishgeneral
IceCure Medical Regains Nasdaq Compliance on Minimum Bid Price
TipRanks59 · neutralgeneral
IceCure (ICCM) Clears Nasdaq’s Minimum Bid Price Hurdle—What Does This Mean for Investors?
MarketChameleon58 · neutralgeneral
IceCure regains compliance with Nasdaq
Seeking Alpha58 · neutralgeneral
IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement
PR Newswire58 · neutralgeneral
ICCM Advances as Peer-Reviewed Journal Highlights Cryoablation Breakthroughs for Early-Stage Breast Cancer
MarketChameleon67 · bullishproduct/pr
Peer-Reviewed Study Finds Cryoablation Offers Distinct Advantages Over Radiofrequency Ablation in Early-Stage Breast Cancer
MarketChameleon63 · neutralproduct/pr
Why Is IceCure Medical Stock (ICCM) Up Today?
TipRanks63 · neutralgeneral
ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally?
Stocktwits News73 · bullishearnings
ICCM’s U.S. Footprint Expands Sharply: ProSense® Install Base Grows 70% Following FDA Clearance
MarketChameleon73 · bullishproduct/pr
ICCM’s ProSense® Installs Surge 70% Post-FDA Clearance as Clinical Guidelines and Patient Awareness Grow
MarketChameleon73 · bullishproduct/pr
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
PR Newswire73 · bullishproduct/pr
IceCure Medical to boost share price with 1-for-30 reverse split to regain Nasdaq compliance
Seeking Alpha25 · bearishgeneral
IceCure Medical Enacts 1-for-30 Reverse Share Split to Bolster Nasdaq Compliance
TipRanks25 · bearishgeneral
IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance | ICCM Stock News
StockTitan25 · bearishgeneral
IceCure Showcases Strong ProSense® Cryoablation Data and Surge in Clinical Interest at ECIO 2026
TipRanks67 · bullishproduct/pr